ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
Luc Dauchet, Marc Lambert, Victoria Gauthier, Julien Poissy, Karine Faure, Alain Facon, Cécile Yelnik, Sophie Panaget, Thierry Plagnieux, Florent Verfaillie, Daniel Mathieu, Patrick Goldstein, Aline Meirhaeghe, Philippe Amouyel on behalf of the Lille COVID-19 study group
doi: https://doi.org/10.1101/2020.04.28.20078071
Luc Dauchet
1CHU Lille, Department of Public Health, Epidemiology, Medical Economy and Prevention, F-59000, Lille, France
2Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, F-59000, Lille, France
MD, PhDMarc Lambert
2Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, F-59000, Lille, France
3CHU Lille, Internal Medicine Department, F-59000, Lille, France
MD, PhDVictoria Gauthier
2Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, F-59000, Lille, France
PharmDJulien Poissy
4CHU Lille, Department of Intensive Care, F-59000, Lille, France
MD, PhDKarine Faure
5CHU Lille, Department of Infectious Diseases, F-59000, Lille, France
6Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d’Infection et d’Immunité de Lille, F-59000, Lille, France
MD, PhDAlain Facon
7CHU Lille. SAMU 59 and Emergency Department, F-59000, Lille, France
MDCécile Yelnik
3CHU Lille, Internal Medicine Department, F-59000, Lille, France
MDSophie Panaget
5CHU Lille, Department of Infectious Diseases, F-59000, Lille, France
MDThierry Plagnieux
8DRSM Hauts de France, F-59009, Villeneuve d’Ascq, France
MDFlorent Verfaillie
8DRSM Hauts de France, F-59009, Villeneuve d’Ascq, France
MDDaniel Mathieu
4CHU Lille, Department of Intensive Care, F-59000, Lille, France
MD, PhDPatrick Goldstein
7CHU Lille. SAMU 59 and Emergency Department, F-59000, Lille, France
MDAline Meirhaeghe
2Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, F-59000, Lille, France
PhDPhilippe Amouyel
1CHU Lille, Department of Public Health, Epidemiology, Medical Economy and Prevention, F-59000, Lille, France
2Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, F-59000, Lille, France
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data can be obtained by contacting the corresponding author
Posted May 01, 2020.
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
Luc Dauchet, Marc Lambert, Victoria Gauthier, Julien Poissy, Karine Faure, Alain Facon, Cécile Yelnik, Sophie Panaget, Thierry Plagnieux, Florent Verfaillie, Daniel Mathieu, Patrick Goldstein, Aline Meirhaeghe, Philippe Amouyel
medRxiv 2020.04.28.20078071; doi: https://doi.org/10.1101/2020.04.28.20078071
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
Luc Dauchet, Marc Lambert, Victoria Gauthier, Julien Poissy, Karine Faure, Alain Facon, Cécile Yelnik, Sophie Panaget, Thierry Plagnieux, Florent Verfaillie, Daniel Mathieu, Patrick Goldstein, Aline Meirhaeghe, Philippe Amouyel
medRxiv 2020.04.28.20078071; doi: https://doi.org/10.1101/2020.04.28.20078071
Subject Area
Subject Areas
- Addiction Medicine (344)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2635)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12204)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4078)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2636)
- Health Policy (1000)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3854)
- Nursing (209)
- Nutrition (572)
- Oncology (2014)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (449)
- Public and Global Health (6509)
- Radiology and Imaging (1395)
- Respiratory Medicine (870)
- Rheumatology (402)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)